2-(1-吡咯烷基)吡啶-3-甲醛 | 690632-39-4

• 物质功能分类: 有机原料 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-(1-吡咯烷基)吡啶-3-甲醛
• 中文别名: 2-(1-吡咯烷)烟醛
• 英文名称: 2-(pyrrolidin-1-yl)-nicotinaldehyde
• 英文别名: 2-(1-Pyrrolidinyl)nicotinaldehyde；2-pyrrolidin-1-ylpyridine-3-carbaldehyde
• CAS: 690632-39-4
• 化学式: C₁₀H₁₂N₂O
• 分子量: 176.218
• InChiKey: FTACFSVJFQMXQE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  33.2
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

SDS

Name:	2-(1-Pyrrolidinyl)nicotinaldehyde Material Safety Data Sheet
Synonym:	None Known
CAS:	690632-39-4

Section 1 - Chemical Product MSDS Name:2-(1-Pyrrolidinyl)nicotinaldehyde Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
690632-39-4	2-(1-Pyrrolidinyl)nicotinaldehyde	97+	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 690632-39-4: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: green
Odor: slight
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H12N2O
Molecular Weight: 176.22

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, amines, bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 690632-39-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-(1-Pyrrolidinyl)nicotinaldehyde - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 24/25 Avoid contact with skin and eyes.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 690632-39-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 690632-39-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 690632-39-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(1-吡咯烷基)吡啶-3-甲醛 在 dirhodium(II) tetrakis(methyl 2-oxopyrrolidine-5(S)-carboxylate) 作用下， 以 乙醇 、 甲苯 为溶剂， 反应 16.0h， 生成 5a,6,7,8-tetrahydro-5H-pyrido[3,2-b]pyrrolizine
  参考文献：
  名称：

  N-二融合吲哚啉通过非羰稳定型铑卡宾Ç ？H插入N-氮杂环丁烷基亚胺

  摘要：

  下铑催化，Ñ提供给访问吖丙啶基亚胺Ñ通过非羰基稳定化-融合二氢吲哚铑卡宾体Ç  ħ插入。方便的全合成（±）-密码啉（参见方案）进一步证明了该方法在合成复杂的杂环结构中的实用性。

  DOI：

  10.1002/chem.201103155
• 作为产物：
  描述：

  四氢吡咯 、 2-氯-3-吡啶甲醛 在 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 以81%的产率得到2-(1-吡咯烷基)吡啶-3-甲醛
  参考文献：
  名称：

  N-二融合吲哚啉通过非羰稳定型铑卡宾Ç ？H插入N-氮杂环丁烷基亚胺

  摘要：

  下铑催化，Ñ提供给访问吖丙啶基亚胺Ñ通过非羰基稳定化-融合二氢吲哚铑卡宾体Ç  ħ插入。方便的全合成（±）-密码啉（参见方案）进一步证明了该方法在合成复杂的杂环结构中的实用性。

  DOI：

  10.1002/chem.201103155

文献信息

• [EN] IMIDAZO [4, 5 - B] PYRIDINE DERIVATIVES AS ALK AND JAK MODULATORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS<br/>[FR] DÉRIVÉS IMIDAZO [4,5-B] PYRIDINE COMME MODULATEURS D'ALK ET DE JAK POUR LE TRAITEMENT DE TROUBLES PROLIFÉRATIFS
  申请人：CEPHALON INC

  公开号：WO2013116291A1

  公开（公告）日：2013-08-08

  This application relates to compounds of the Formula I as defined herein, and/or salts thereof. This application further relates to compositions and methods of using these compounds and/or salts thereof. The compounds of Formula I are useful as ALK and JAK modulators for the treatment of proliferative disorders.

  这项申请涉及到本文所定义的Formula I化合物及/或其盐。此申请进一步涉及到使用这些化合物和/或其盐的组合物和方法。Formula I化合物可用作ALK和JAK调节剂，用于治疗增殖性疾病。
• [EN] HETEROARYL AND PHENYL SUBSTITUTED THIENO [2,3-D] PYRIMIDINES AND THEIR USE AS ADENOSINE A2A RECEPTOR ANTAGONISTS<br/>[FR] THIÉNO[2,3-D]PYRIMIDINES À SUBSTITUTION HÉTÉROARYLE ET PHÉNYLE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DU RÉCEPTEUR A2A DE L'ADÉNOSINE
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2010045012A1

  公开（公告）日：2010-04-22

  This invention relates to a novel thieno[2,3-d]pyrimidine, Z, and its therapeutic and prophylactic uses, wherein R1 and R2 are definedin the specification. Disorders treated and/or prevented include Parkinson's Disease.

  这项发明涉及一种新型噻吩[2,3-d]嘧啶化合物Z及其治疗和预防用途，其中R1和R2在规范中有定义。治疗和/或预防的疾病包括帕金森病。
• Hydride Transfer Initiated Redox-Neutral Cascade Cyclizations of Aurones: Facile Access to [6,5] Spirocycles
  作者：Kang Duan、Xiao-De An、Long-Fei Li、Lian-Lian Sun、Bin Qiu、Xian-Jiang Li、Jian Xiao

  DOI：10.1021/acs.orglett.0c00309

  日期：2020.4.3

  Reported herein is the hydride transfer initiated redox-neutral cascade cyclizations of aurones, providing a variety of [6,5] spiro-heterocycles in satisfactory yields and good diastereoselectivities.

  本文报道的是氢化物转移引发的氧化还原中性级联环氧化，可提供令人满意的收率和良好的非对映选择性的各种[6,5]螺杂环。
• Zinc chloride catalyzed stereoselective construction of spiropyrazolone tetrahydroquinolines via tandem [1,5]-hydride shift/cyclization sequence
  作者：Tuan Zhao、Huanrui Zhang、Longchen Cui、Jingping Qu、Baomin Wang

  DOI：10.1039/c5ra18471a

  日期：——

  A zinc chloride catalyzed tandem 1,5-hydride shift/cyclization process to form spiropyrazolone terahydroquinoline derivatives is developed. A series of new spiropyrazolone derivatives were obtained in good to high yields with good to excellent diastereoselectivities (up to 95% yield, >95 : 5 dr). Additionally, the spiropyrazolone derivatives could be converted into the corresponding novel spriopyrazolines

  开发了氯化锌催化串联1,5-氢化物转变/环化工艺以形成螺吡唑酮四氢喹啉衍生物。以高至高收率获得了一系列新的螺并吡唑啉酮衍生物，非对映选择性很好（高达95％，> 95：5 dr）。另外，螺并吡唑啉酮衍生物可以转化为相应的新型螺并吡唑啉。
• Fluorinated alcohol mediated <i>N</i>,<i>N</i>′-dialkylation of amino acid derivatives <i>via</i> cascade [1,5]-hydride transfer/cyclization for concise synthesis of tetrahydroquinazoline
  作者：Hongjin Shi、Lubin Xu、Didi Ren、Liang Wang、Weisi Guo、Shuai-Shuai Li

  DOI：10.1039/c9ob02498k

  日期：——

  Structurally diverse amino acids and their ester derivatives were conveniently N,N'-dialkylated via a TFE-promoted cascade condensation/[1,5]-hydride transfer/cyclization for straightforward construction of pharmeutically significant tetrahydroquinazolines incorporating various amino acids, which featured broad substrate scope, the use of TFE as a sole solvent, additive-free and mild conditions.

  通过TFE促进的级联缩合/ [1,5]-氢化物转移/环化反应，可以方便地将结构多样的氨基酸及其酯衍生物进行N，N'-二烷基化，以直接构建结合了多种氨基酸，具有广泛底物的药学上重要的四氢喹唑啉。范围，使用TFE作为唯一溶剂，无添加剂且条件温和。